Flubrotizolam (FANAX) – 0.5mg

A. Introduction

Flubrotizolam (FANAX) 0.5mg pellets are premium laboratory-grade research pellets containing fluorobrominated thienotriazolodiazepine, designed for scientific institutions and analytical laboratories investigating high-potency benzodiazepine analogs. This high-purity microdose pellet format provides researchers with consistent 0.5mg units for ultra-trace method validation, forensic screening, and reference material preparation in controlled settings.

B. Scientific Overview

Flubrotizolam belongs to the thienotriazolodiazepine class structurally similar to brotizolam, characterized by its fused thiophene-triazole-benzodiazepine scaffold with 2-fluoro and 2-bromo substitutions suitable for analytical profiling. In research contexts, it functions as an analytical reference for studying chromatographic behavior, mass spectrometry fragmentation patterns, and spectroscopic signatures of designer benzodiazepines.

Laboratory investigations focus on its chemical properties including sub-microgram solubility profiles, thermal stability, and quantitative recovery characteristics under LC-MS/MS conditions, without reference to biological interactions.

C. Product Specifications

• Form: Compressed microdose pellets containing 0.5mg flubrotizolam per unit for precise lab handling

• Label per unit: 0.5mg analytical portions (resealable packaging)

• Synonym: FANAX, JYI-73

• CAS Number: 57801-95-3

• Molecular Formula: C₁₇H₁₂BrFN₄S

• Molecular Weight: 419.28 g/mol

• Purity: ≥98% (HPLC, typical batch purity)

• Storage Conditions: -20°C freezer, desiccated, protected from light/moisture for maximum stability

D. Laboratory Use Context

Flubrotizolam (FANAX) 0.5mg pellets are designated solely for in-vitro analytical research, including ultra-trace reference standard preparation, LC-HRMS method validation at pg/mL concentrations, forensic toxicology screening for designer benzodiazepines, and impurity profiling in complex biological matrices.

Researchers apply them in controlled environments for quantitative analysis at forensic limits of detection, positive ESI ionization studies ([M+H]+), and stability assessment via UHPLC-QTOF protocols. The microdose pellet format facilitates reproducible sub-microgram transfers essential for method LOQ determination.

E. Quality & Testing

Every batch receives comprehensive quality control:

• Certificate of Analysis (COA) with HPLC, LC-MS/MS, NMR identity confirmation and pellet uniformity testing

• Full batch traceability from synthesis through pellet compression and verification

• Third-party ISO 17025 accredited laboratory testing for content uniformity (<3% RSD), homogeneity, and residual solvents

• Manufactured under controlled conditions ensuring consistent microdose deposition and long-term stability

F. Shipping & Handling

Discreet worldwide shipping to verified research laboratories via secure, temperature-controlled carriers meeting IATA/DOT standards for Schedule I research chemicals. Specialized low-moisture packaging with desiccant protection and full import documentation provided. Tracking included; buyers confirm jurisdictional compliance prior to purchase.

G. Compliance Disclaimer

For Research Use Only. Not for human consumption.
This product constitutes a controlled laboratory reagent supplied strictly for analytical research purposes. Not approved for human, veterinary, diagnostic, or therapeutic applications. No statements imply biological activity beyond controlled in-vitro analytical contexts.

Qualified researchers and institutions assume complete responsibility under local, federal, and international regulations. Seller disclaims all liability for non-research applications. Consult material safety data sheets and institutional handling protocols before use.